Every earnings call for DEEPAKNTR — management tone, guidance, KPIs and promise tracking, quarter by quarter.
DEEPAKNTR · 7 transcripts · Chemicals · latest Q4 FY26Consolidated Revenue ₹2,127 cr (−3% YoY); Consolidated EBITDA ₹383 cr (+13% YoY); Consolidated EBITDA Margin 18%. Consolidated revenues for Q4 FY26 stood at INR 2,127 crore, with PAT growing 120% QoQ to INR 220 crore.
Read full transcript & analysisRevenue ₹1,983 cr (+3% YoY); EBITDA ₹219 cr (+16% YoY); EBITDA Margin 11%. Consolidated revenue of INR 1,983 crore, up 3% YoY and QoQ.
Read full transcript & analysisRevenue ₹1,922 cr; EBITDA ₹224 cr; EBITDA Margin 12%. Consolidated Revenue stood at ₹1,922 crores, a marginal sequential increase from ₹1,914 crores in Q1 FY26.
Read full transcript & analysisRevenue ₹1,897 cr; EBITDA ₹197 cr; EBITDA Margin 10%. Consolidated Revenue reported at ₹1,897 crore, representing a 7% sequential decline excluding government incentives.
Read full transcript & analysisRevenue ₹8,366 cr (+8% YoY); EBITDA ₹1,176 cr (−2% YoY); EBITDA Margin 14%. Consolidated Revenue for FY25 reached ₹8,366 crores, representing an 8% YoY growth.
Read full transcript & analysisRevenue ₹1,924 cr (−5% YoY); EBITDA ₹190 cr (−40% YoY); PAT ₹98 cr. Consolidated Revenue of ₹1,924 crore, down 5% YoY and 6% QoQ due to a 'perfect storm' of challenges.
Read full transcript & analysisRevenue ₹2,053 cr (+14% YoY); EBITDA ₹319 cr; EBITDA Margin 15%. Consolidated Revenue reached ₹2,053 crores in Q2 FY25, a 14% YoY growth driven by the Phenolics segment.
Read full transcript & analysis